First published on ScienceDaily
Research into curious bright spots in the eyes on stroke patients’ brain images could one day alter the way these individuals are assessed and treated. A team of scientists at the National Institutes of Health found that a chemical routinely given to stroke patients undergoing brain scans can leak into their eyes, highlighting those areas and potentially providing insight into their strokes. The study was published in Neurology.
“We were kind of astounded by this — it’s a very unrecognized phenomenon,” said Richard Leigh, M.D., an assistant clinical investigator at the NIH’s National Institute of Neurological Disorders and Stroke (NINDS) and the paper’s senior author. “It raises the question of whether there is something we can observe in the eye that would help clinicians evaluate the severity of a stroke and guide us on how best to help patients.” (more…)
Botulinum toxin has been used for almost 30 years to treat spasticity. Out of these experiences it shows that botulinum does not cause long-term side effects. Microscopic examinations showed that no permanent changes have occurred in the nerves or muscles after absorbing Botulinum. After the effect ends, neither the active substance nor its effects on the nerves can be detected. As a calm muscle is usually weaker (think of a leg in a cast), with time a smaller dose of Botulinum toxin is going to be needed, to get the same muscle relaxing effect than before. (more…)
The Stroke Action Plan for Europe draft document will become available for comments on 26th February 2018. It will be posted on a link, initially shared by ESO on their website and Social media accounts.
The link will lead to the whole document, containing texts from all 7 domains. The document will be in form of PDF and open for all comments, once you register and log in.
It will remain available for comments for two full weeks, starting from 27th February 2018.
SAFE will share the link from ESO’s website as soon as it becomes available, and we would like to encourage as many people as possible to get involved and help SAFE and ESO in shaping up recommendations for stroke prevention, treatment and rehabilitation from 2018 to 2035.
Image by pixabay.com
Too few patients with retinal infarction, or loss of blood flow in the eye, are evaluated for stroke risk or seen by a neurologist, putting them at increased risk for another stroke, according to preliminary research presented at the American Stroke Association’s International Stroke Conference 2018, a world premier meeting dedicated to the science and treatment of cerebrovascular disease for researchers and clinicians. (more…)
A diet created by researchers at Rush University Medical Center may help substantially slow cognitive decline in stroke survivors, according to preliminary research presented on Jan. 25 at the American Stroke Association’s International Stroke Conference 2018 in Los Angeles. The findings are significant because stroke survivors are twice as likely to develop dementia compared to the general population.
The diet, known as the MIND diet, is short for Mediterranean-DASH Diet Intervention for Neurodegenerative Delay. The diet is a hybrid of the Mediterranean and DASH (Dietary Approaches to Stop Hypertension) diets. Both have been found to reduce the risk of cardiovascular conditions such as hypertension, heart attack and stroke. (more…)
First published on ScienceDaily
An experimental therapy being tested by University of Alberta scientists that targets the spinal cord may one day be key to spurring on enhanced recovery for stroke victims.
By injecting a drug called chondroitinase ABC (ChABC) into the spinal cord of rats 28 days after they suffered a stroke, researchers found they were able to enhance recovery by inducing amplified rewiring of circuits connecting the brain to the spinal cord. When they also combined the spinal therapy with rehabilitative training, recovery amplified further. (more…)
Tamro, Finland’s leading service provider and distributor of pharmaceuticals and health products, pronounced winners of The Health Awards 2018. The judges voted the Finnish Brain Association’s blood pressure campaign as the Health Act of the Year. Nightingale Health’s blood analysis for the prevention of cardiovascular diseases was selected as the Health Innovation of the Year. As stated on their website, with The Health Awards, Tamro rewards work that has effectively promoted the health of Finns, as well as brings promising innovations to the spotlight. Both winners received a prize of € 5 000. (more…)
IMPERIAL NEWS; by Ryan O’Hare, Imperial College London.
A new multi-million Euro initiative funded by the European Commission has been set up to help prevent stroke in patients with existing conditions
The €6.9m project is aimed at patients with atrial fibrillation (AF), a common heart condition which causes irregular and abnormally fast heartbeat, who have previously had a stroke caused by bleeding in the brain (termed intracerebral haemorrhage or ICH).
The Prevention of Stroke in intracerebral hermorrhage survivor with Atrial Fibrillation (PRESTIGE-AF) brings together scientists and clinicians across Europe with the goal of reducing the risk of further stroke in this group of patients. (more…)
The proportion of a rare type of stroke, called spontaneous subarachnoid hemorrhage or sSAH, is increasing among pregnant women, according to preliminary research presented at the American Stroke Association’s International Stroke Conference 2018, a world premier meeting dedicated to the science and treatment of cerebrovascular disease for researchers and clinicians.
Spontaneous SAH is an abnormality within the brain’s arteries that weaken and leads to ruptures in the blood vessels on the surface of the brain, causing bleeding between the membranes surrounding the brain. Spontaneous SAH refers to hemorrhage that occurs without trauma to the head or neck. (more…)
Fewer than one in 100 stroke survivors meet all of Life’s Simple 7 goals for ideal cardiovascular health identified by the American Heart Association. Moreover, the proportion who fail to meet almost all of the criteria is on the rise, according to preliminary research presented at the American Stroke Association’s International Stroke Conference 2018, a world premier meeting dedicated to the science and treatment of cerebrovascular disease for researchers and clinicians. (more…)